Landmark Non-Small Cell Lung Cancer Study - Clinically Meaningful Improvement and Progression Free Survival, Alexander I. Spira, MD, PhD, FACP 

Lung Cancer Team, The Research Institute, Alex Spira, Clinical Trials and Research, Lung Cancer, Non-Small Cell Lung Cancer
September 28, 2023
Read More

NEXT-Virginia Opens Phase I Clinical Research Clinic for Oncology Patients in collaboration with Virginia Cancer Specialists

NEXT Oncology, The Research Institute, Alex Spira, Clinical Trials and Research, Press Releases
January 10, 2023
Read More

Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial

NEXT Oncology, The Research Institute, Alex Spira, Non-Small Cell Lung Cancer
June 27, 2022
Read More

2022 Clinical Trials Day Virginia Cancer Specialists

Fairfax Cancer Center, Events, The Research Institute, Clinical Trials and Research
May 20, 2022
Read More

Molecular Tumor Board offer patients diagnosed with cancer access to personalized medicine - Timothy A. McCarthy, MD

Precision Medicine, Tumor Boards, Cancer Tumor, The Research Institute, Clinical Trials and Research, Timothy A. McCarthy
December 9, 2021
Read More

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

The Research Institute, Alex Spira, Clinical Trials and Research, Mitul Gandhi
October 11, 2021
Read More

Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

The Research Institute, Alex Spira, Clinical Trials and Research, Lung Cancer
February 4, 2021
Read More

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

The Research Institute, Alex Spira
October 8, 2018
Read More

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

The Research Institute, Alex Spira, Amy J. Irwin MD
May 22, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

The Research Institute, Alex Spira, Clinical Trials and Research, Leukemia
March 6, 2018
Read More

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More
Return to Top